Mezzion Sues Dr. Reddy’s for Concealing GMP Deficiencies That Resulted in An NDA Rejection

Drug Industry Daily
Mezzion filed a lawsuit accusing its former manufacturer Dr. Reddy of fraud for concealing significant GMP deficiencies that resulted in the FDA’s refusal to approve an NDA for udenafil, an erectile dysfunction therapy.

To View This Article:


Subscribe To Drug Industry Daily